Coherent Corp. filings document the formal disclosures of a Pennsylvania operating company whose common stock trades on the New York Stock Exchange under COHR. Recent Form 8-K reports cover quarterly operating results, Regulation FD investor materials, executive transition matters, shareholder-vote results and capital-structure events.
The filing record also documents securities registered under Section 12(b), a completed private placement of common stock to NVIDIA, Series B convertible preferred stock and a dividend-rights waiver by its holder. These disclosures connect Coherent's photonics operations with governance, ownership, financing and reporting matters, including exhibits furnished with earnings releases and investor presentations.
Coherent Corp. director reported a sale of company stock. On 12/03/2025, the reporting person sold 2,000 shares of Coherent Corp. common stock in an open-market transaction coded as a sale. The weighted average sale price was $164.5111 per share, reflecting multiple trades within a range from $164.41 to $164.54. After this transaction, the director beneficially owned 8,645 shares of Coherent Corp. common stock directly.
Coherent Corp.'s Senior Vice President of Finance reported a small insider sale of company stock. On 12/01/2025, the executive sold 1,377 shares of Coherent common stock in an open market transaction coded "S" at a price of $162.71 per share. After this transaction, the officer still beneficially owns 24,033 shares of Coherent common stock, held directly. The filing is signed by an attorney-in-fact on behalf of the reporting person.
Coherent Corp. director reports option exercise and share sales. A director of Coherent Corp. (COHR) exercised an option to acquire 2,000 shares of common stock at an exercise price of $21.67 per share on 12/02/2025. On the same date, the director reported selling 1,000 shares at $168 per share and another 1,000 shares at $172 per share.
Following these transactions, the director reported owning 50,019 shares of common stock directly. The filing also shows an option (right to buy) covering 2,000 underlying shares with an exercise price of $21.67 and an expiration date of 08/20/2026, with 6,240 derivative securities beneficially owned after the reported activity. The option originally vested in four equal annual installments beginning on 08/17/2017.
Coherent Corp. shareholder plans to sell 2,000 common shares under Rule 144. The shares were acquired on 08/28/2024 through restricted stock vesting under a registered plan and are expected to be sold around 12/03/2025 on the NYSE. The planned sale, through Morgan Stanley Smith Barney LLC Executive Financial Services, has an indicated aggregate market value of $329,022. Coherent common shares outstanding were 157,153,611 at the time noted.
Coherent (COHR) has a Form 144 notice indicating that an affiliate plans to sell 2,000 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE. The shares have an aggregate market value of $340,000 based on the figures provided, compared with 157,153,611 common shares outstanding. The seller acquired these 2,000 shares on 12/02/2025 by exercising stock options under a registered plan and paid cash for the exercise.
During the prior three months, Howard H. Xia sold 1,000 common shares for gross proceeds of $158,360. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about Coherent’s current or prospective operations.
Coherent Corp. director reports stock option exercise and share sale. A company director filed a Form 4 disclosing that on 11/28/2025 they exercised an option to acquire 1,000 shares of Coherent Corp. common stock at an exercise price of $21.67 per share, then sold 1,000 shares of common stock at a price of $158.36 per share on the same date.
Following these transactions, the director beneficially owned 50,019 shares of Coherent Corp. common stock and 8,240 derivative securities (stock options). The reported option originally vested in four equal annual installments beginning on August 17, 2017.
COHR filed a notice that a holder plans to sell common shares under Rule 144. The planned sale covers 1,377 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $224,051.67 and an approximate sale date of 12/01/2025. These 1,377 shares were acquired as restricted stock from the issuer on 08/28/2024, with payment made the same day. The filing notes that 157,153,611 shares of this class were outstanding, providing context for the size of the proposed sale.
A shareholder of COHR has filed a Form 144 notice to potentially sell 1,000 shares of common stock on the NYSE through Morgan Stanley Smith Barney LLC. The shares have an aggregate market value of 158360.00, compared with 157,153,611 shares outstanding, so this is a very small transaction relative to the company’s total equity.
The securities to be sold were acquired on 11/28/2025 by exercising stock options under a registered plan, with the purchase price paid in cash on the same date. Form 144 indicates the filer’s intent to rely on Rule 144 for resales and confirms that the filer represents not knowing any undisclosed material adverse information about the issuer.
Coherent Corp. director reports stock sale
A director of Coherent Corp. (COHR) reported selling 2,831 shares of Coherent common stock on 11/21/2025 at a price of $134.85 per share. After this transaction, the director beneficially owns 21,078 shares of Coherent common stock in direct ownership. The filing is a routine Form 4 disclosure of insider trading activity required by U.S. securities regulations.
BCPE Watson (DE) BML, LP, an affiliate of Bain Capital, updated its ownership report for Coherent Corp. common stock. The reporting person now beneficially owns 14,868,245 shares of common stock, representing 7.9% of the class, primarily through convertible Series B preferred stock. On November 24, 2025, it converted 20,977 shares of Series B-1 and 33,135 shares of Series B-2 preferred into 7,592,307 common shares and sold 7,500,000 common shares in a Rule 144 block trade at $143.37 per share, for total proceeds of $1,075,275,000. The holder plans to distribute 92,307 common shares to its members or partners for charitable gifts for no consideration. A new Conversion Cap Agreement limits its beneficial ownership to 9.99%, and a Waiver Agreement gives up rights to dividends on all Series B preferred stock on or after November 20, 2025.